Based on this YouTube video's total view count of 155 views and industry-standard rates, the estimated total earning is $0 - $0 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.

Explore Fabry Disease: Is The Risk of Kidney Failure Being Properly Managed By Your Medical Team? with 155 views, 27 likes, and 0 comments. Experience the impact of this video content that has captured audience attention.

This educational program, hosted by Dawn Laney, MS, CGC, CCRC, Genetic Counselor and Program Leader for the Lysosomal Storage Disease Center at Emory University, and Staci Kallish, DO, Associate Professor of Clinical Medicine in the Division of Translational Medicine and Human Genetics at the University of Pennsylvania, examines how best to respond to patients concerns about how their Fabry disease, and its comorbidities, are managed. This program features a dialogue between patients who express their unmet needs, while two renowned Fabry disease experts translate these challenges into actionable clinical strategies. Topic covered in this video segment is whether the risk of kidney failure is being properly addressed by medical teams. This educational program is a non-CME activity made possible by an unrestricted grant from Amicus Therapeutics Faculty Dawn Laney, MS, CGC, CCRC Genetic Counselor, Division of Medical Genetics Program Leader, Lysosomal Storage Disease Center Emory University School of Medicine Disclosures Consulting agreements: Amicus Therapeutics, Chiesi, Sanofi Member: North American and International Fabry Registry Boards Staci Kallish, DO Associate Professor of Clinical Medicine Division of Translational Medicine and Human Genetics Perelman School of Medicine, University of Pennsylvania Disclosures Research grants: ashibio, Astellas Pharma, , Amicus Therapeutics Idorsia Therapeutics, Incyte , Ipsen, and Sanofi Consulting: Amicus Therapeutics, Sanofi Advisory board: Amicus Therapeutics, Intrabio, Sanofi Speaking honoraria: Amicus Therapeutics, Astellas, Sanofi Learning Objective Upon completion of this program, participants will be able to: • Identify and overcome barriers to managing kidney concerns in patients with Fabry disease.

With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.

Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.

Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.

Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.